Glatiramer: cutaneous necrosis.
D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009336:Necrosis / Q000139:chemically induced*; D010455:Peptides / Q000009:adverse effects* / Q000627:therapeutic use; D012867:Skin / Q000473:pathology
D010455:Peptides